科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Antimicrobial Agents and Chemotherapy2025-11-18· Linezolid

Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum

Yusuke Hashimoto, Duc Trung Dao, Ikuro Kasuga, Taichiro Takemura, Haruka Abe, Futoshi Hasebe, Takahiro Nomura, Jun Kurushima, Hidetada Hirakawa, Koichi Tanimoto, Pham Duy Thai, Tran Huy Hoang, Keigo Shibayama, Masato Suzuki, Haruyoshi Tomita

原始摘要(英文原文)· Original abstract
Vancomycin and linezolid are crucial for treating enterococcal infections. The global emergence of linezolid- and vancomycin-resistant enterococci is a growing concern. Enterococcal pELF-type linear plasmids, which confer both types of resistance, have been identified worldwide from clinical and environmental sources. Phylogenetic and structural analyses of pELF-type linear plasmids revealed that they diverged into two distinct lineages and evolved through the integration of circular plasmids. Our findings on this ongoing evolution advance the fundamental knowledge required for the future development of global and cross-sectoral surveillance.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum — 科研速览 Science Skim